Gnörich, Johannes
Reifschneider, Anika
Wind, Karin
Zatcepin, Artem
Kunte, Sebastian T.
Beumers, Philipp
Bartos, Laura M.
Wiedemann, Thomas
Grosch, Maximilian
Xiang, Xianyuan
Fard, Maryam K.
Ruch, Francois
Werner, Georg
Koehler, Mara
Slemann, Luna
Hummel, Selina
Briel, Nils
Blume, Tanja
Shi, Yuan
Biechele, Gloria
Beyer, Leonie
Eckenweber, Florian
Scheifele, Maximilian
Bartenstein, Peter
Albert, Nathalie L.
Herms, Jochen
Tahirovic, Sabina
Haass, Christian
Capell, Anja
Ziegler, Sibylle
Brendel, Matthias
Funding for this research was provided by:
Alzheimer Forschung Initiative e.V. (18014)
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy (390857198)
Koselleck Project (HA1737/16-1)
Universitätsklinik München
Article History
Received: 3 July 2022
Accepted: 13 February 2023
First Online: 24 February 2023
Declarations
:
: The experiments have been approved by the local animal care committee of the Government of Oberbayern (Regierung Oberbayern), overseen by a veterinarian and in compliance with the ARRIVE guidelines and were carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments.
: Not applicable.
: CH collaborates with Denali Therapeutics, participated on one advisory board meeting of Biogen, and received a speaker honorarium from Novartis and Roche. CH is chief advisor of ISAR Bioscience and a member of the advisory board of AviadoBio. MB received speaker honoraria from Roche, GE healthcare and Life Molecular Imaging and is an advisor of Life Molecular Imaging.